Altimmune, Inc. (ALT) Tops Q4 EPS by 1c

Altimmune, Inc. (NASDAQ: ALT) reported Q4 EPS of ($0.33), $0.01 better than the analyst estimate of ($0.34).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Antero Resources (AR) PT Raised to $47 at Benchmark on Natural Gas Bull Case
• Activist Ancora Now Seeks to Buy H.B. Fuller Adhesives Unit - Bloomberg
• Asia Broadband reports record $14.9M in H1 2026 gold and silver revenue